ASX News Health Care Immutep dips as safety test for flagship drug IMP761 shows no adverse effects Immutep has reported a small-scale conceptual safety test among 5 patients using flagship drug IMP761 has… Jonathon Davidson1 min17 December 2024 10:27 (AEDT)